EMEA-002031-PIP01-16-M01

Key facts

Active substance
Emapalumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0152/2018
PIP number
EMEA-002031-PIP01-16-M01
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of haemophagocytic lymphohistiocytosis
Route(s) of administration
Intravenous use
Contact for public enquiries
Novimmune B.V.

Tel. +41 228397141
E-mail: pip@novimmune.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating